nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Estropipate—osteoporosis	0.371	0.518	CbGbCtD
Ximelagatran—CYP2C9—Cholecalciferol—osteoporosis	0.191	0.267	CbGbCtD
Ximelagatran—CYP2C9—Estradiol—osteoporosis	0.154	0.215	CbGbCtD
Ximelagatran—F2—Common Pathway—FGA—osteoporosis	0.0134	0.0483	CbGpPWpGaD
Ximelagatran—F2—Common Pathway—FGB—osteoporosis	0.0122	0.0439	CbGpPWpGaD
Ximelagatran—F2—Blood Clotting Cascade—FGA—osteoporosis	0.0114	0.0411	CbGpPWpGaD
Ximelagatran—F2—Blood Clotting Cascade—FGB—osteoporosis	0.0104	0.0374	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—TLN1—osteoporosis	0.01	0.0363	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00841	0.0304	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—RAP1A—osteoporosis	0.00828	0.0299	CbGpPWpGaD
Ximelagatran—F2—Formation of Fibrin Clot (Clotting Cascade)—FGA—osteoporosis	0.00768	0.0277	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—FGA—osteoporosis	0.00751	0.0271	CbGpPWpGaD
Ximelagatran—F2—Formation of Fibrin Clot (Clotting Cascade)—FGB—osteoporosis	0.00698	0.0252	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—FGB—osteoporosis	0.00683	0.0247	CbGpPWpGaD
Ximelagatran—F2—vertebral column—osteoporosis	0.00632	0.877	CbGeAlD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGF1—osteoporosis	0.00487	0.0176	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00486	0.0175	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—FGB—osteoporosis	0.0047	0.017	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—GSN—osteoporosis	0.00469	0.0169	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00384	0.0139	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD2—osteoporosis	0.00353	0.0128	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—MGLL—osteoporosis	0.00349	0.0126	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL1B—osteoporosis	0.00337	0.0122	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—VCL—osteoporosis	0.00325	0.0117	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—ACTG1—osteoporosis	0.00325	0.0117	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00312	0.0113	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.00311	0.0112	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00305	0.011	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD2—osteoporosis	0.00287	0.0104	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00279	0.0101	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—GPX1—osteoporosis	0.00274	0.00991	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MTHFR—osteoporosis	0.00253	0.00914	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—WDR1—osteoporosis	0.0025	0.00904	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.0024	0.00869	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00237	0.00857	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD2—osteoporosis	0.00228	0.00825	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00225	0.00812	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00222	0.00801	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTH1R—osteoporosis	0.00221	0.00799	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CALCR—osteoporosis	0.00221	0.00799	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—GPX1—osteoporosis	0.00218	0.00787	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00201	0.00726	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00198	0.00716	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAP1—osteoporosis	0.00198	0.00715	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—osteoporosis	0.00185	0.00667	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00182	0.00658	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.0018	0.00649	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.00164	0.00591	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCT2—osteoporosis	0.00163	0.00589	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00163	0.00587	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MGLL—osteoporosis	0.00157	0.00568	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—osteoporosis	0.0015	0.00543	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00149	0.00537	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ANXA2—osteoporosis	0.00144	0.00519	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLEK—osteoporosis	0.00144	0.00519	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TUBA1B—osteoporosis	0.00139	0.00501	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoporosis	0.00136	0.00492	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—osteoporosis	0.00134	0.00484	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTH1R—osteoporosis	0.00125	0.00452	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CALCR—osteoporosis	0.00125	0.00452	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TLN1—osteoporosis	0.00124	0.00448	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VCL—osteoporosis	0.00122	0.00442	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—osteoporosis	0.00119	0.00431	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00118	0.00426	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00116	0.00421	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTH—osteoporosis	0.00116	0.0042	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTH1R—osteoporosis	0.00114	0.0041	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CALCR—osteoporosis	0.00114	0.0041	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CNR2—osteoporosis	0.00113	0.00409	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.00111	0.00402	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—RPL24—osteoporosis	0.00111	0.00401	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—osteoporosis	0.00109	0.00394	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—osteoporosis	0.00108	0.00391	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—WNT1—osteoporosis	0.00107	0.00385	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAP1A—osteoporosis	0.00102	0.00369	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—MGLL—osteoporosis	0.000994	0.00359	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TLN1—osteoporosis	0.000975	0.00352	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000968	0.0035	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTHLH—osteoporosis	0.000963	0.00348	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000957	0.00346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000954	0.00345	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—REN—osteoporosis	0.000937	0.00339	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FGA—osteoporosis	0.000927	0.00335	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MGLL—osteoporosis	0.000902	0.00326	CbGpPWpGaD
Ximelagatran—F2—bone marrow—osteoporosis	0.000886	0.123	CbGeAlD
Ximelagatran—F2—Folate Metabolism—IL6—osteoporosis	0.00088	0.00318	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—POMC—osteoporosis	0.000869	0.00314	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—osteoporosis	0.000866	0.00313	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CALCA—osteoporosis	0.000848	0.00306	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FGB—osteoporosis	0.000843	0.00305	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000768	0.00277	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SOST—osteoporosis	0.000742	0.00268	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.00074	0.00267	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000709	0.00256	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—osteoporosis	0.000699	0.00252	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALCR—osteoporosis	0.000671	0.00242	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTH1R—osteoporosis	0.000671	0.00242	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTH—osteoporosis	0.000657	0.00237	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000647	0.00234	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR2—osteoporosis	0.00064	0.00231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000613	0.00222	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTH—osteoporosis	0.000597	0.00216	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—osteoporosis	0.000585	0.00211	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000583	0.0021	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR2—osteoporosis	0.000581	0.0021	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000575	0.00208	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—WNT1—osteoporosis	0.000547	0.00197	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTHLH—osteoporosis	0.000544	0.00197	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MGLL—osteoporosis	0.000533	0.00193	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LRP5—osteoporosis	0.00052	0.00188	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	0.000508	0.00184	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000501	0.00181	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LRP6—osteoporosis	0.000498	0.0018	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTHLH—osteoporosis	0.000494	0.00179	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CALCA—osteoporosis	0.000479	0.00173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000477	0.00172	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000465	0.00168	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000444	0.0016	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—osteoporosis	0.000444	0.0016	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CALCA—osteoporosis	0.000435	0.00157	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TLN1—osteoporosis	0.00042	0.00152	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—osteoporosis	0.000382	0.00138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000372	0.00134	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—osteoporosis	0.000363	0.00131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—P4HB—osteoporosis	0.000362	0.00131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTH—osteoporosis	0.000352	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAP1A—osteoporosis	0.000346	0.00125	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR2—osteoporosis	0.000343	0.00124	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000342	0.00124	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADCY5—osteoporosis	0.000341	0.00123	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFATC1—osteoporosis	0.000338	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DKK1—osteoporosis	0.000335	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—WNT1—osteoporosis	0.000323	0.00117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000316	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGA—osteoporosis	0.000314	0.00113	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—osteoporosis	0.000312	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADCY5—osteoporosis	0.00031	0.00112	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—osteoporosis	0.000306	0.0011	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—osteoporosis	0.0003	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTHLH—osteoporosis	0.000292	0.00105	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BMP2—osteoporosis	0.000292	0.00105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PKM—osteoporosis	0.000288	0.00104	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FDPS—osteoporosis	0.000288	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGB—osteoporosis	0.000286	0.00103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMA2—osteoporosis	0.000276	0.000997	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMA5—osteoporosis	0.000276	0.000997	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PGLS—osteoporosis	0.000273	0.000987	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPD2—osteoporosis	0.000273	0.000987	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALCA—osteoporosis	0.000257	0.000929	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—osteoporosis	0.000251	0.000906	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PNP—osteoporosis	0.00025	0.000903	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ATIC—osteoporosis	0.00025	0.000903	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KL—osteoporosis	0.000233	0.000843	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—osteoporosis	0.000229	0.000827	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—osteoporosis	0.000228	0.000823	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6R—osteoporosis	0.000222	0.000802	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA2—osteoporosis	0.000212	0.000767	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—OXCT1—osteoporosis	0.000212	0.000767	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MGLL—osteoporosis	0.000207	0.000748	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000195	0.000705	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADCY5—osteoporosis	0.000183	0.000661	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPP1—osteoporosis	0.000177	0.000639	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IDH2—osteoporosis	0.000176	0.000636	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP27A1—osteoporosis	0.000165	0.000598	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACP5—osteoporosis	0.000161	0.000582	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS2—osteoporosis	0.00016	0.000578	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000159	0.000574	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—osteoporosis	0.000157	0.000566	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPI1—osteoporosis	0.00015	0.000541	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—osteoporosis	0.000149	0.00054	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—P4HB—osteoporosis	0.000141	0.000508	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS1—osteoporosis	0.00014	0.000505	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GAPDH—osteoporosis	0.000138	0.000499	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RAP1A—osteoporosis	0.000135	0.000486	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—osteoporosis	0.000135	0.000486	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6R—osteoporosis	0.000131	0.000474	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—osteoporosis	0.000129	0.000467	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000117	0.000424	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO1—osteoporosis	0.000109	0.000393	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMA2—osteoporosis	0.000107	0.000387	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMA5—osteoporosis	0.000107	0.000387	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—osteoporosis	9.89e-05	0.000357	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP19A1—osteoporosis	8.69e-05	0.000314	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—osteoporosis	7.78e-05	0.000281	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—osteoporosis	7.76e-05	0.00028	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADCY5—osteoporosis	7.1e-05	0.000257	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—osteoporosis	7.08e-05	0.000256	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—osteoporosis	6.53e-05	0.000236	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—osteoporosis	5.85e-05	0.000211	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—osteoporosis	5.22e-05	0.000189	CbGpPWpGaD
